BeStock  
Markets › Compare › PEN vs ABT

PEN vs ABT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PEN · Penumbra$318.59 ▲ 0.08%
ABT · Abbott Laboratories$97.53 ▼ 1.32%

Head to head

MetricPENABT
Price$318.59$97.53
Change today▲ 0.08%▼ 1.32%
Market cap$12.55B$168.76B
Return, 3 months–+6.6%
Return, year to date–-20.7%
Return, 1 year–-25.2%
P/E (TTM)78.331.6
P/B8.23.3
P/E percentile vs own 5y–69th
Dividend yield–2.50%
Revenue growth (YoY, latest qtr)–+13.0%
Net profit growth (YoY)–-47.8%
Gross margin–56.6%
Operating margin–15.8%
Net margin–11.6%
Return on equity–10.7%
Analyst target vs. price+12.5%+27.5%
Analyst buy share17%100%
RSI (14)–30
30-day volatility–20.3%
Max drawdown, 1 year–-38.6%
Trend read–Strong downtrend
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ABT is the largest of the group by market value.
  • ABT carries the lowest trailing P/E.

Go deeper

Scroll to Top